We are live on
!
Find out more
Lazard Asset Management Portfolio holdings
AUM
$60.8B
1-Year Est. Return
22.47%
This Fund
S&P 500
This Quarter
Est. Return
+4.73%
1 Year Est. Return
+22.47%
3 Year Est. Return
+62.53%
5 Year Est. Return
+77.87%
10 Year Est. Return
+302.07%
AUM
$58.4B
AUM Growth
+$3.16B
(+5.7%)
Cap. Flow
+$130M
Cap. Flow
% of AUM
0.22%
Top 10 Holdings %
Top 10 Hldgs %
22.35%
Holding
1,144
New
156
Increased
347
Reduced
289
Closed
87
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PG&E
PCG
|
+$395M |
| 2 |
AT&T
T
|
+$334M |
| 3 |
Intel
INTC
|
+$252M |
| 4 |
Wabtec
WAB
|
+$225M |
| 5 |
Steel Dynamics
STLD
|
+$224M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
K
Kellanova
K
|
+$317M |
| 2 |
PPG Industries
PPG
|
+$300M |
| 3 |
Baidu
BIDU
|
+$279M |
| 4 |
Crown Holdings
CCK
|
+$227M |
| 5 |
Madison Square Garden
MSGS
|
+$219M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.17% |
| 2 | Communication Services | 14.39% |
| 3 | Industrials | 13.01% |
| 4 | Financials | 11.45% |
| 5 | Healthcare | 10.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
201
Oracle
ORCL
$345B
| $38.3M | 0.07% |
811,093
+41,585
| +5% | +$2.04M |
|
|
PACW
202
DELISTED
PacWest Bancorp
PACW
| $38.2M | 0.07% |
757,345
-266,545
| -26% | -$12.7M |
|
|
MON
203
DELISTED
Monsanto Co
MON
| $38.2M | 0.07% |
326,805
-114,295
| -26% | -$13.6M |
|
204
iShares Core S&P Small-Cap ETF
IJR
$110B
| $37.7M | 0.06% |
490,626
-11,169
| -2% | -$842K |
|
205
Cigna
CI
$77B
| $37.6M | 0.06% |
185,037
+13,115
| +8% | +$2.61M |
|
206
Consolidated Edison
ED
$41.1B
| $36.7M | 0.06% |
432,294
-13,843
| -3% | -$1.19M |
|
|
GAM
207
General American Investors Company
GAM
$1.54B
| $36.7M | 0.06% |
1,066,707
-35,000
| -3% | -$1.22M |
|
208
Elevance Health
ELV
$82.1B
| $36.3M | 0.06% |
161,175
+55,706
| +53% | +$11.9M |
|
|
NSA
209
DELISTED
National Storage Affiliates Trust
NSA
| $36.2M | 0.06% |
1,327,446
+71,928
| +6% | +$1.85M |
|
210
Ingevity
NGVT
$2.59B
| $36.2M | 0.06% |
513,444
+6,908
| +1% | +$498K |
|
211
HCA Healthcare
HCA
$86.4B
| $36M | 0.06% |
409,726
+88,524
| +28% | +$7.11M |
|
212
AMN Healthcare
AMN
$1.3B
| $35.9M | 0.06% |
728,241
-160,267
| -18% | -$7.3M |
|
213
iShares Core S&P Mid-Cap ETF
IJH
$123B
| $35.8M | 0.06% |
942,705
-85,730
| -8% | -$3.17M |
|
214
Altria Group
MO
$122B
| $35.6M | 0.06% |
499,001
-236,167
| -32% | -$15.8M |
|
|
MSF
215
DELISTED
Morgan Stanley Emerging Mkts Fd
MSF
| $35.5M | 0.06% |
1,986,364
-224,363
| -10% | -$3.94M |
|
|
CEO
216
DELISTED
CNOOC Limited
CEO
| $35.4M | 0.06% |
246,453
-1,425
| -0.6% | -$193K |
|
217
Labcorp
LH
$24.7B
| $35.2M | 0.06% |
256,856
+962
| +0.4% | +$127K |
|
218
Core Laboratories
CLB
$518M
| $34.4M | 0.06% |
314,039
+21,420
| +7% | +$2.14M |
|
219
Liberty All-Star Equity Fund
USA
$1.76B
| $34.1M | 0.06% |
5,420,018
-176,900
| -3% | -$1.09M |
|
220
CSX Corp
CSX
$96B
| $34M | 0.06% |
1,854,699
-255,741
| -12% | -$4.53M |
|
221
Air Products & Chemicals
APD
$65.2B
| $33.6M | 0.06% |
204,846
+204,838
| +2,560,475% | +$32.6M |
|
222
PNC Financial Services
PNC
$99.6B
| $33.1M | 0.06% |
229,404
+62,048
| +37% | +$8.57M |
|
223
MetLife
MET
$61.2B
| $33M | 0.06% |
651,840
-122,522
| -16% | -$6.45M |
|
224
Synopsys
SNPS
$74.5B
| $32.6M | 0.06% |
382,174
+13,612
| +4% | +$1.18M |
|
225
iShares Core MSCI Emerging Markets ETF
IEMG
$150B
| $32.5M | 0.06% |
571,011
-66,308
| -10% | -$3.7M |
|
Similar funds
QCM
Lazard Asset Management's Q4 2017 Portfolio in Review
As of Q4 2017, Lazard Asset Management held 1,144 positions worth $58.4B, up 5.7% from $55.3B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Lazard Asset Management's Q4 2017 filing shows 156 new, 347 increased, 289 reduced and 87 closed positions. Its largest new stake was Sterling Bancorp: 7,076,120 shares worth $174M. The largest sale was Kellanova, an estimated $317M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Communication Services and Industrials.
- Lazard Asset Management's largest Q4 2017 buy was Sterling Bancorp: 7,076,120 shares worth $174M.
- Lazard Asset Management added most to PG&E in Q4 2017, an estimated $395M increase.
- Lazard Asset Management's biggest Q4 2017 reduction was Kellanova, cutting an estimated $317M.
- Lazard Asset Management fully exited Woodward in Q4 2017, selling an estimated $30.8M.
- Lazard Asset Management's ten largest holdings make up 22% of its $58.4B portfolio in Q4 2017.
- Lazard Asset Management opened 156 new positions and closed 87 in Q4 2017.
- Lazard Asset Management's portfolio value rose 5.7% quarter-over-quarter to $58.4B.
Based on Lazard Asset Management's 13F filing for Q4 2017, filed 13 Feb 2018.